Hydroxychloroquine Retinopathy
Journal of Rheumatic Diseases
;
: 140-145, 2015.
Artículo
en Coreano
| WPRIM
| ID: wpr-36849
ABSTRACT
Hydroxychloroquine (HCQ) has been widely used for treatment of various rheumatic and dermatologic diseases. However, under a high cumulative dose, HCQ may cause retinal toxicity. In this review, we summarize the underlying mechanisms, prevalence, risk factors, clinical characteristics, screening tests, treatments, and prognosis of HCQ retinopathy. Because HCQ retinopathy is rarely reversible, screening tests to determine the retinal toxicity prior to its development are important. The American Academy of Ophthalmology screening protocols for early detection were updated in 2013. However, as a different clinical type is found in Asian patients, predominantly the pericentral type of photoreceptor damage, rather than the traditional parafoveal type, we propose a modified screening protocol for detection of HCQ retinopathy in Korean and other Asian patients.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Oftalmología
/
Pronóstico
/
Retina
/
Retinaldehído
/
Tamizaje Masivo
/
Prevalencia
/
Factores de Riesgo
/
Pueblo Asiatico
/
Hidroxicloroquina
Tipo de estudio:
Estudio de etiología
/
Guía de Práctica Clínica
/
Estudio de prevalencia
/
Estudio pronóstico
/
Factores de riesgo
/
Estudio de tamizaje
Límite:
Humanos
Idioma:
Coreano
Revista:
Journal of Rheumatic Diseases
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS